Skip to main content

Milestone 14.D

Develop partnerships that expand the precompetitive space through clinical proof of concept mechanism to accelerate translational learning and to fill critical knowledge gaps in understanding the network biology of drug targets and drug-target interactions.  


Success Criteria

  • Establish at least one precompetitive partnership to validate the therapeutic targets that will be delivered by the Accelerating Medicines Partnership for AD (AMP-AD), as well as other pioneer targets, through clinical proof of mechanism/proof of concept.


Research Implementation Area
Public Private Partnerships
Timeline
2016–2022
Status
To Be Initiated

Relevant Recommendations